Grace Wang

3.7k citations
106 papers · 2.6k indexed · h-index 27
Topics
Cancer Treatment and Pharmacology (8 papers)HER2/EGFR in Cancer Research (7 papers)Health Systems, Economic Evaluations, Quality of Life (6 papers)
Partner nations
United StatesCanadaChina

In The Last Decade

Grace Wang

100 papers receiving 2.6k citations

Peers

Grace Wang
Comparison fields: 5 of 161
  • Oncology 568
  • Molecular Biology 554
  • Pathology and Forensic Medicine 381
  • Cancer Research 343
  • Immunology 248
Replace Michael E. Scheurer with:
Michael E. Scheurer United States
Logan G. Spector United States
Chong Ae Kim Brazil
Simona Iodice Italy
Manuel Posada de la Paz Spain
Ute Latza Germany
Róza Ádány Hungary
Corrado Magnani Italy
Jacqueline Clavel France
Grace Wang relative to Michael E. Scheurer United States Michael E. Scheurer's profile →
Citations per field
00.5×1.7×
Michael E. Scheurer · 1×
Citations per year

Countries citing papers authored by Grace Wang

Since Specialization
Citations

This map shows the geographic impact of Grace Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Wang more than expected).

Fields of papers citing papers by Grace Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Wang. The network helps show where Grace Wang may publish in the future.

Co-authorship network of co-authors of Grace Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Grace Wang. A scholar is included among the top collaborators of Grace Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace Wang. Grace Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 1
6 0
7 37
8 90
9 3
10 15
11 14
12 22
13 11
14 2
15 20
16 92
17 42
18 172
19 39
20 5

About Grace Wang

Grace Wang is a scholar working on Oncology, Transplantation and Speech and Hearing, having authored 106 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). The work is most often cited by research in Cancer Research (343 citations), Speech and Hearing (153 citations) and Pathology and Forensic Medicine (381 citations). Grace Wang has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Mark J. Mendell, Wanda Phipatanakul, Watcharoot Kanchongkittiphon, Jonathan M. Gaffin, Tianqing Peng, Guo‐Chang Fan, Maria‐Laura Mancianti, Joy Wang, Ervin H. Epstein and Miriam Kuppermann. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026